Cowen Healthcare Investments

Portfolio Co Investors 2026 for Cowen Healthcare Investments: investors, rounds, and co-investor patterns from StartupFundraising.com research.

Cowen Healthcare Investments accounts for 20 tracked companies with verified cap-table data, 20 of which disclose round sizes totalling $3.3B. The median disclosed raise is $156M, and the largest is TORL BioTherapeutics at $450M, ahead of Pliant Therapeutics ($251M) and Arch Oncology ($241M).

The names that recur most often on these co-invested cap tables are Cowen Healthcare Investments (20 companies), Redmile Group (4 companies), OrbiMed (3 companies), Perceptive Advisors (3 companies), BVF Partners (3 companies), Venrock (3 companies). By latest disclosed round, the market skews Series B (8), Series C (7), Series A (2), IPO (1).

Best funded Cowen Healthcare Investments companies

  1. TORL BioTherapeutics — $450M (latest: Series C)
  2. Pliant Therapeutics — $251M (latest: IPO)
  3. Arch Oncology — $241M (latest: Series C)
  4. Escient Pharmaceuticals — $238M (latest: Series C)
  5. Scipher Medicine — $225M (latest: Series A)
  6. Neuron23 — $214M (latest: Series D)
  7. Personal Genome Diagnostics — $199M (latest: Series C)
  8. AM Pharma — $176M (latest: Series C)
  9. Autobahn Therapeutics — $176M (latest: Series B)
  10. Anaveon — $156M (latest: Series B)
  11. Repare Therapeutics — $151M (latest: Series B)
  12. Oncorus — $141M (latest: Series B)
  13. enGene — $135M (latest: Growth)
  14. Nested Therapeutics — $125M (latest: Series A)
  15. Blueprint Medicines — $115M (latest: Series C)

Cowen Healthcare Investments — related firms and companies (56)

Cowen Healthcare Investments alternatives · All research reports